Debrisoquine

Debrisoquine[1]
Names
	IUPAC name 1,2,3,4-tetrahydroisoquinoline-2-carboximidamide
Identifiers
CAS Number	1131-64-2 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:34665 ;
ChEMBL	ChEMBL169901 ;
ChemSpider	2860 ;
DrugBank	DB04840 ;
ECHA InfoCard	100.013.155
KEGG	C13650 ;
MeSH	Debrisoquine
PubChem CID	2966;
UNII	X31CDK040E ;
CompTox Dashboard (EPA)	DTXSID7022885 ;
	InChI InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12) Key: JWPGJSVJDAJRLW-UHFFFAOYSA-N ; InChI=1/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12) Key: JWPGJSVJDAJRLW-UHFFFAOYAE;
	SMILES [N@H]=C(N)N2Cc1c(cccc1)CC2;
Properties
Chemical formula	C10H13N3
Molar mass	175.23032
Pharmacology
ATC code	C02CC04 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug-metabolizing enzyme.[2]

References

Debrisoquine – Compound Summary, PubChem.
Fuhr, U.; Jetter, A.; Kirchheiner, J. (2007). "Appropriate Phenotyping Procedures for Drug Metabolizing Enzymes and Transporters in Humans and Their Simultaneous Use in the "Cocktail" Approach". Clinical Pharmacology & Therapeutics. 81 (2): 270–283. doi:10.1038/sj.clpt.6100050.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Debrisoquine – Compound Summary, PubChem.

[2] Fuhr, U.; Jetter, A.; Kirchheiner, J. (2007). "Appropriate Phenotyping Procedures for Drug Metabolizing Enzymes and Transporters in Humans and Their Simultaneous Use in the "Cocktail" Approach". Clinical Pharmacology & Therapeutics. 81 (2): 270–283. doi:10.1038/sj.clpt.6100050.

Debrisoquine

See also

References